Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on July 14, 2025
Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners
GlobeNewswire
·
July 14, 2025
London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- At the Brunel Hack 25 - Blockchain Hackathon …
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
GlobeNewswire
·
July 14, 2025
SAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced results from an independent, real- …
Woodward Schedules Fiscal 2025 Third Quarter Earnings Release and Conference Call
GlobeNewswire
·
July 14, 2025
FORT COLLINS, Colo., July 14, 2025 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ: WWD) announced today that it expects to report its fiscal 2025 third quarter financial results at approximately 4:00 p.m. ET on Monday, July 28, 2025. A news release will be …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
July 14, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
Gauzy, in Collaboration with Research Frontiers, Announces Its SPD Smart Glass in Serial Production for GM’s Cadillac CELESTIQ, Now Being Delivered to Customers
GlobeNewswire
·
July 14, 2025
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ), a global leader in light and vision control technologies, joined by Research Frontiers (NASDAQ: REFR), today announced the first customer delivery of General Motors’ Cadillac CELESTIQ, …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
July 14, 2025
PR N°C3347C STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from July 7, 2025 to July 11, 2025 AMSTERDAM – July 14, 2025 -- STMicroelectronics N.V. (the “Company” or “ …
Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer
GlobeNewswire
·
July 14, 2025
--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief of staff to the CEO SAN DIEGO, July 14 …
MKS Inc. Announces Second Quarter 2025 Earnings Conference Call
GlobeNewswire
·
July 14, 2025
ANDOVER, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release second quarter 2025 financial results after market close on …
INSPIRED Launches New Social Media Platform that Brings Together Innovators, Investors and Collaborators to Fuel Purpose-Driven Ideas
GlobeNewswire
·
July 14, 2025
ZÜRICH, Switzerland, July 14, 2025 (GLOBE NEWSWIRE) -- INSPIRED today announces the launch of its new social media platform where innovators, investors and collaborators can connect to turn world-changing ideas into reality. By empowering purpose-driven …
JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)
GlobeNewswire
·
July 14, 2025
IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating the …
HYTN Secures Cannabis Drug Licence, Advancing Prescription Drug Pathway for Cannabinoid-Based Medicines
GlobeNewswire
·
July 14, 2025
VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has received a …
LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has improved its climate change score from A-minus to A in CDP’s 2024 assessment, placing the company in the leadership category for the second consecutive year. CDP …
Casella Waste Systems, Inc. Signs Agreement For Acquisition Of West Virginia-Based Mountain State Waste
GlobeNewswire
·
July 14, 2025
RUTLAND, Vt., July 14, 2025 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (Nasdaq: CWST), a regional solid waste, recycling, and resource management services company (the “Company”), today announced that it has signed an agreement for the acquisition of …
Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time
GlobeNewswire
·
July 14, 2025
DALLAS, July 14, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) …
TopBuild to Release Second Quarter 2025 Results on Tuesday, August 5
GlobeNewswire
·
July 14, 2025
DAYTONA BEACH, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, announced it …
Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
GlobeNewswire
·
July 14, 2025
TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, today announced that Health …
Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)
GlobeNewswire
·
July 14, 2025
TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), une société biopharmaceutique spécialisée dans la mise au point et la commercialisation de nouveaux traitements contre des maladies génétiques rares et très rares, …
Rumble Names Ian O’Donnell VP for Rumble Cloud
GlobeNewswire
·
July 14, 2025
LONGBOAT KEY, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced the hiring of Ian O’Donnell, a 20-year veteran of technology sales and marketing, as the company’s Vice …
Study: First Brain Fitness Tracker Validated for Aging Independently
GlobeNewswire
·
July 14, 2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- A new study shows that a novel online assessment (here) provides a valid scientific measure of the cognitive abilities of older adults related to living independently. The self-administered assessment can be …
Gero Appoints Longevity Expert Dr. Brian Kennedy to Board of Directors
GlobeNewswire
·
July 14, 2025
SINGAPORE, July 14, 2025 (GLOBE NEWSWIRE) -- Gero, an AI-driven biotechnology company focused on developing therapeutics for age-related diseases, today announced the appointment of Brian Kennedy, Ph.D., to its Board of Directors. Dr. Kennedy is a globally …